Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence

By Cicero Arrigo FG   Tartagni Elisa   Ertek Sibel  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 6, 2014-06 ,pp. : 863-868

Informa Healthcare

Access to resources Recommend Favorite

Transforming Growth Factor-β₁ Increases the Expression of Lectin-like Oxidized Low-Density Lipoprotein Receptor-1

By Minami M.   Kume N.   Kataoka H.   Morimoto M.   Hayashida K.   Sawamura T.   Masaki T.   Kita T.  

Biochemical and Biophysical Research Communications, Vol. 272, Iss. 2, 2000-06 ,pp. : 357-361

Elsevier

Access to resources Recommend Favorite

Protection by quercetin and quercetin 3- O -β-D-glucuronide of peroxynitrite-induced antioxidant consumption in human plasma low-density lipoprotein

By Terao Junji   Yamaguchi Sachiyo   Shirai Mutsuko   Miyoshi Mariko   Moon Jae-Hak   Oshima Syunji   Inakuma Takahiro   Tsushida Tojiro   Kato Yoji  

Free Radical Research, Vol. 35, Iss. 6, 2001-01 ,pp. : 925-931

Informa Healthcare

Access to resources Recommend Favorite

Preferential apelin‐13 production by the proprotein convertase PCSK3 is implicated in obesity

By  

FEBS Open Bio, Vol. 3, Iss. 1, 2013-01 ,pp. : 328-333

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lovastatin Increases Surface Low Density Lipoprotein Receptor Expression by Retarding the Receptor Internalization Rate in Proliferating Lymphocytes

By Chan P.C.   Lafreniere R.   Parsons H.G.  

Biochemical and Biophysical Research Communications, Vol. 235, Iss. 1, 1997-06 ,pp. : 117-122

Elsevier

Access to resources Recommend Favorite